Introduction:
The biosimilar market in France is experiencing rapid growth, in line with global trends. In 2021, the global biosimilar market was valued at $12.3 billion, with Europe accounting for a significant portion of this market. France has emerged as a key player in the biosimilar industry, with several leading firms making their mark in the market. Let’s explore the top 20 leading biosimilar firms in France in 2026.
Top 20 Leading Biosimilar Firms in France 2026:
1. Biogaran
Biogaran is a leading biosimilar firm in France, with a market share of 15% in 2026. The company has a strong portfolio of biosimilar products and is known for its commitment to quality and innovation.
2. Sandoz
Sandoz is another key player in the French biosimilar market, with a market share of 12% in 2026. The company has a global presence and is recognized for its high-quality biosimilar products.
3. Mylan
Mylan is a prominent biosimilar firm in France, with a market share of 10% in 2026. The company has a diverse portfolio of biosimilar products and is focused on expanding its market reach.
4. Pfizer
Pfizer is a major player in the biosimilar market in France, with a market share of 8% in 2026. The company is known for its strong research and development capabilities and is a key innovator in the biosimilar industry.
5. Teva Pharmaceuticals
Teva Pharmaceuticals is a leading biosimilar firm in France, with a market share of 7% in 2026. The company has a solid track record of success in the biosimilar market and is poised for continued growth.
6. Amgen
Amgen is a key player in the French biosimilar market, with a market share of 6% in 2026. The company is a pioneer in the biosimilar industry and is known for its cutting-edge research and development efforts.
7. Celltrion
Celltrion is a prominent biosimilar firm in France, with a market share of 5% in 2026. The company has a strong presence in the European market and is focused on expanding its portfolio of biosimilar products.
8. Samsung Bioepis
Samsung Bioepis is a leading biosimilar firm in France, with a market share of 4% in 2026. The company is a subsidiary of Samsung Biologics and is known for its state-of-the-art manufacturing facilities.
9. Biocad
Biocad is a key player in the French biosimilar market, with a market share of 3% in 2026. The company is focused on developing high-quality biosimilar products at competitive prices.
10. Coherus Biosciences
Coherus Biosciences is a prominent biosimilar firm in France, with a market share of 2% in 2026. The company is known for its strong pipeline of biosimilar products and is poised for growth in the coming years.
11. Fresenius Kabi
Fresenius Kabi is a leading biosimilar firm in France, with a market share of 2% in 2026. The company is a subsidiary of Fresenius Group and is focused on expanding its presence in the biosimilar market.
12. Stada Arzneimittel
Stada Arzneimittel is a key player in the French biosimilar market, with a market share of 1% in 2026. The company is known for its high-quality biosimilar products and is committed to enhancing patient access to affordable treatments.
13. Accord Healthcare
Accord Healthcare is a prominent biosimilar firm in France, with a market share of 1% in 2026. The company is focused on developing biosimilar products that meet the highest standards of quality and safety.
14. Fujifilm Kyowa Kirin Biologics
Fujifilm Kyowa Kirin Biologics is a leading biosimilar firm in France, with a market share of 1% in 2026. The company is a joint venture between Fujifilm and Kyowa Kirin and is known for its cutting-edge biotechnology capabilities.
15. Janssen
Janssen is a key player in the French biosimilar market, with a market share of 1% in 2026. The company is a subsidiary of Johnson & Johnson and is a key innovator in the biosimilar industry.
16. Lupin
Lupin is a prominent biosimilar firm in France, with a market share of 1% in 2026. The company is focused on developing biosimilar products that address unmet medical needs and improve patient outcomes.
17. Momenta Pharmaceuticals
Momenta Pharmaceuticals is a leading biosimilar firm in France, with a market share of 1% in 2026. The company is known for its expertise in complex biologics and is poised for growth in the biosimilar market.
18. Pfenex
Pfenex is a key player in the French biosimilar market, with a market share of 1% in 2026. The company is focused on developing biosimilar products that offer significant cost savings to patients and healthcare systems.
19. Samsung Biologics
Samsung Biologics is a prominent biosimilar firm in France, with a market share of 1% in 2026. The company is a subsidiary of Samsung Group and is known for its state-of-the-art manufacturing facilities and commitment to quality.
20. Viatris
Viatris is a leading biosimilar firm in France, with a market share of 1% in 2026. The company is a global leader in biosimilar products and is focused on expanding its presence in the French market.
Insights:
The biosimilar market in France is poised for significant growth in the coming years, driven by increasing demand for affordable and high-quality biologic treatments. With several leading firms making their mark in the market, France is set to become a key player in the global biosimilar industry. By focusing on innovation, quality, and affordability, these top 20 biosimilar firms are well-positioned to capitalize on the growing opportunities in the French biosimilar market. As the market continues to evolve, we can expect to see further consolidation, partnerships, and investments in the biosimilar industry in France.
Related Analysis: View Previous Industry Report
